Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

Clinical trial NCT00368927 · COMPLETED

Trial details

NCT number: NCT00368927
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Precancerous Condition Stage I Non-small Cell Lung Cancer Tobacco Use Disorder

Start date: 2006-08-01
Primary completion: 2010-05-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.